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SUMMARY
Forty-seven acoustic neurinoma tumours have been operated on in 46 patients
in the years 1987- 1989. This is a considerable increase over the prevalence in
the preceding ten years. Twenty -six were classified as large tumours, 18 as
medium and one was small. Surgical excision wascomplete in 16 and incomplete
in 31 cases. Two patients died in the early postoperative period. Facial nerve
function was preserved in 36 (80%) of cases; of these, 27 (60%) had good
function and nine (20%) fair function. Useful hearing was preserved in only two
patients. The overall complication rate has been low and often of a transitory
nature.
INTRODUCTION
Acoustic neurinoma presents a challenge both in diagnosis and treatment. The
diagnostic challenge is to detect early and therefore smaller tumours, whilst the
surgical challenge is to remove what is a benign tumour with as little morbidity as
possible.
Reports of these tumours date back to 1830, when Sir Charles Bell I published
the first clinical and autopsy case of cerebellopontine angle neurinoma. The first
successful operation on an acoustic neurinoma was performed by Ballance2 in
1894. Cushing3 developed an interest in these tumours in the early twentieth
century and by performing partial removal was able to reduce to 20 % the
previous operative mortality of 80%. His technique was refined by Dandy,4 one
of his students, who removed the capsule after enucleation of the tumour interior
with a mortality rate of 22%, although all his patients were deaf and had
permanent total facial paralysis.
Further advances were made in the 1960s when House5 developed the trans-
labyrinthine approach with microsurgical removal. He achieved a 5% mortality
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rate, and preserved facial nerve function in almost 95% following total tumour
removal. Recent advances have been mainly in the field ofdiagnostic techniques,
allowing smaller tumours to be identified. These twin improvements, in surgical
technique and in diagnosis, have led to a further reduction in mortality and overall
morbidity. Facial nerve function is commonly preserved and in selected patients
preservation of hearing may now be a realistic goal. In the ten years between
1976 and 1986 40 acoustic neurinomas were removed surgically in the Royal
Victoria Hospital,6 an average of four per year. In the last three years 47 tumours
have been removed, an increaseto over 15 peryear. The raesonsfor this increase
may include heightened awareness among the medical community, the more
widespread provision of CT scanners and increased expectations by patients.
The results of the surgery in the last three years are reported.
PATIENTS AND METHODS
Forty-six patients were operated on for 47 tumours between September 1986
and February 1990. Three patients had bilateral tumours: in one the first side
had been dealt with before September 1986 and in a second only one side has
been operated on so far. There were 18 males and 28 females. Ages ranged from
19 to 73 years with an average age of 48 years.
Symptoms on presentation are shown in Table 1. All patients complained of
deafness. The next most common symptoms were unsteadiness and tinnitus.
Rotatory vertigo occurred in eight patients. Other symptoms included headache,
facial numbness or pain, diplopia, blurring of vision and nausea and vomiting.
The first symptom was deafness alone in 33 patients, unsteadiness in six, tinnitus
in three, and both deafness and tinnitus together in another four.
TABLE I
Symptoms on presentation in 46 patients
n (%)
Deafness 46 100
Unsteady gait 24 52
Tinnitus 23 50
Rotatory vertigo 8 17
Headache 7 15
Facial pain/numbness 4 8
Diplopia 2 2
Blurred vision 2 4
Vomiting 2 4
Nausea in morning 1 2
Physical signs on presentation in addition to deafness are shown in Table II.
Twenty -one patients were ataxic on walking with a positive Romberg's test, and a
further four showed arm ataxia. Nystagmus was present in 15, decreased corneal
reflexes in nine, and decreased facial sensation in seven patients. Other signs
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included papilloedema (4), facial weakness (3), absent or diminished gag reflex
(3), and vocal cord paresis or hypoglossal paralysis. Eighteen patients showed no
physical signs whatsoever other than deafness.
TABLE II
Physical signs on presentation in addition to deafness
n (%)
Ataxia -gait 21 45
-arm 4 8
Nystagmus 15 32
Decreased corneal reflex 9 19
Decreased facial sensation 7 15
Papilloedema 4 8
Facial weakness 3 6
Absent/diminished gag reflex 3 6
Vocal cord paresis 1 2
Hypoglossal paralysis 1 2
No other signs 18 39
Three clinical stages are recognised. In stage I only the eighth nerve is involved
with deafness and tinnitus being the only symptoms. Stage 11 is marked by the
presence of other neurological signs or symptoms usually cerebellar ataxia and
trigeminal nerve or nucleus involvement. Stage III tumours cause raised intra-
cranial pressure and usually papilloedema.
In this series there were 18 stage 1, 25 stage 11 and 4 stage III tumours on present-
ation. One tumour was small (less than 1 cm), 20 were medium sized tumours
(1 - 2-5 cm) and 26 were large (greater than 2-5 cm diameter). The patient with
the small tumour had previously had surgery on the opposite side for an acoustic
neurinoma, with nystagmus preoperativelyand wastherefore classified as stage II.
All reported tumours were removed by a combined neurosurgical and otological
team using the suboccipital approach.
RESULTS
There were two postoperative deaths, which occurred in patients who had large
tumours. A 58-year -old female died a few hours postoperatively from a brain
stem infarct, and a 63-year-old male developed chest problems in the early
postoperative period and eventualy died of respiratory failure.
Sixteen tumours were completely removed and 31 incompletely removed
(Table 111). Most complete removals were in medium sized tumours. Of the
incomplete removals 1 1 were subtotal, 17 were partial capsular and three were
intracapsular. Reasons for incomplete removal included age or debility, fluctuat-
ing vital signs, swelling of the brain or bleeding at surgery, attempts to preserve
auditory or facial nerve function and tumour adherence to the brain stem.
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TABLE III
Tumour size and stage at presentation and surgical excision
Tumour stage Excision
I I/ I1 complete incomplete
Small 1 1
Medium 1 1 9 13 7
Large 7 15 4 3 23
Facial nerve function
Postoperative facial nerve function in 45 patients is shown in Table IV. Function
was graded as absent, fair when weakness and asymmetry were marked and
good when normal or near normal. The two patients who died in the early post-
operative period are not included. Facial nerve function was preserved in 36
(80%) of patients. Of these function was good in 27 (60%) and fair in 9 (20%).
Nine patients had no residual function (20%). Two ofthe patients with fair results
are expected to improve further. In the 15 patients where tumour excision was
complete, facial nerve function was preserved in 14, of whom 11 had a good
result. Of the nine patients with no postoperative facial nerve function eight had
large tumours, seven of which were incompletely removed.
TABLE IV
Facial nervefunction postoperatively. (Two cases who died have been excluded)
Excision Good Fair None Total
Small Incomplete 1 - 1
Medium Complete 10 3 - 13
Incomplete 4 2 1 7
Large Complete 1 1 2
Incomplete 11 4 7 22
Total 27 9 9 45
Hearing
If a speech discrimination score of 50% is considered to be essential for useful
hearing, then 14 patients has useful hearing preoperatively. This includes one ear
with a score of less than 50% in a patient who had bilateral tumours and total loss
of hearing in the other ear, his only hearing ear therefore was considered useful.
Hearing was preserved in this patient and in only one other. All other patients had
no useful hearing postoperatively. Two patients were referred directly to neuro-
surgery from medical and neurological clinics and because ofthe large size ofthe
tumours audiometry was not performed. These two patients have been excluded
from consideration of hearing.
© The Ulster Medical Society, 1992.
42Acoustic neurinoma
Complications
The overall complication ratehas been low. Twenty -one patients had nocomplic-
ations whatsoever. There were no cases of wound infection or meningitis. Fifteen
patients showed ataxia to some degree which has completely settled in eight so
far, improved in a further five but continues to present a problem in two cases
who need an aid to walk. Dysphagia was present in five patients initially, and has
resolved in two of them. Four of the patients with dysphagia, plus one other
patient, had vocal cord paresis postoperatively, two of whom have settled. Other
complications included headache and facial pain in four cases and single cases of
dysarthria or blurred vision. Cerebrospinal fluid otorhinorrhoea occurred in one
patient due to incomplete waxing of mastoid air cells, which required further
surgery.
To date two patients who had partial capsular removals have shown evidence of
regrowth on CT scanning and will probably require further surgery.
DISCUSSION
The mortality rate for acoustic neurinoma surgery via the suboccipital route
remains low, and was 4 3% in this series. Facial nerve function was preserved in
80% of the 45 patients, and in 14 of the 15 patients where tumour excision was
complete. The likelihood of hearing preservation is low. Postoperative morbidity
has been low and often of a transient nature. It is well recognised that surgery on
smaller tumours results in fewer complications. However, although Brainstem
Evoked Response Audiometry can indicate, and CT scanning can detect small
tumours, it is interesting to note that only one tumour was picked up at this stage.
Whilst this compares favourably with the previous 10 year period where 78% of
the tumours were large at presentation,6 it would decrease morbidity if these
tumours could be detected earlier. Hearing preservation is only likely with small
tumours. The tumour size distribution here is similar to that reported in other
series. Cohn et al7 noted no change in size distribution from 1979 to 1986, whilst
Glasscock8 noted a decrease in large and an increase in medium tumours but no
change in the number of small tumours presenting between 1975 and 1985.
Similarly Thomsen9 had only one small tumour in 300 cases, the majority being
large tumours greater than 2
- 5 cm.
An advantage of the translabyrinthine approach is that it avoids damage to the
cerebellum and therefore produces less ataxia postoperatively. Thomsen9 noted
a 7%o incidence of ataxia using this approach. Ataxia was a problem in only two of
our cases both of whom were elderly. Cerebrospinal fluid leakage is a relatively
common complication in other series, especially with the translabyrinthine
approach, occurring in up to 20% ofcases.10-13 This occurred in only one patient
in this series (2.2%). Facial nerve function was preserved in 80% (60% with a
good result) which is similar to other series.9 14, 15 Hardy et al 14 pointed out that
the presence of preoperative facial weakness and a tumour size greater than
2 * 5 cm diameter are poor prognostic signs for facial nerve recovery.
It would seem that despite the surgical advances, increased diagnostic ability and
more widespread provision of this technology, little apparent effect on early
diagnosis has occurred. Perhaps education of the medical community to refer
earlier the patients complaining of asymmetrical hearing loss is the way forward.
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